Fifteen years of tobacco tax reform show countries can make harmful products less affordable - World Health Organization (WHO)
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Major tobacco-tax reforms in several emerging economies have sharply increased cigarette prices and helped drive down smoking, offering powerful lessons for countries seeking to protect health, raise revenue and advance the World Health Organization’s 3 by 35 Initiative. A new independent analysis of 15 countries finds that every country made improvements to cigarette taxation between 2009 and 2025. The strongest results came where governments acted boldly, substantially raising taxes, simplifying tax systems and preventing cigarettes from becoming more affordable as incomes rose. WHO urges countries to use health taxes to increase the real prices of tobacco, alcohol and sugary drinks by 2035. The 3 by 35 Initiative aims to reduce consumption of products that drive noncommunicable diseases and injuries, while generating resources that governments can invest in health and development. “The evidence is clear: when governments make harmful products significantly more expensive, people consume less, lives are saved and public revenues rise,” said Dr Etienne Krug, Director, Department of Health Determinants, Promotion and Prevention, WHO.
This article is an excerpt. To read the full content, visit the original source. World Health Organization (WHO)
Related articles
Financial Incentives Boost Tobacco Abstinence in Underserved Adults - Ophthalmology Advisor
Among medically underserved adults referred for lung cancer screening, the rates of sustained tobacco abstinence are higher with financial incentives versus usual care with or without free pharmacotherapy. HealthDay News — Among medically underserved adults referred for lung cancer screening, the rates of sustained tobacco abstinence are higher with financial incentives versus usual care with or without free pharmacotherapy, according to a study published online Oct. 5 in the Journal of the American Medical Association.
Tobacco and infertility: An overlooked public health challenge - World Health Organization (WHO)
Tobacco smoking may be harming your chances of having a baby - World Health Organization (WHO)
Bioengineer.org | Switching HIV drugs or adding zoledronic acid rebuilds bone lost to tenofovir - European AIDS Treatment Group
Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.
0 comments
No comments yet. Be the first to share your thoughts!